Inventor · disambiguated record
Liang Zeng Yan
Also filed as: YAN LIANG · YAN LIANG Z · YAN LIANG ZENG
12 granted patents·6 pending applications·23 citations·filing 2002–2024
86Inventor score
Files withLILLY CO ELI4COHBAR INC3MAINLINE BIOSCIENCES SHANGHAI CO LTD3MAINLINE BIOSCIENCES LLC2Mainline Biosciences2
Top patents by PatentIndex Score
18 records- 0190US11123437B2Selective CXCR4 binding peptide conjugate and methods for making and using the sameMAINLINE BIOSCIENCES LLC·Filed 2020·Granted Sep 21, 2021·4 cites·33 claims
- 0283US11111271B2Therapeutic peptidesCOHBAR INC·Filed 2017·Granted Sep 7, 2021·6 cites·33 claims
- 0382US11332497B2Therapeutic peptidesCOHBAR INC·Filed 2021·Granted May 17, 2022·1 cites·28 claims
- 0481US10639379B2High affinity CXCR4 selective binding conjugate and method for using the sameMAINLINE BIOSCIENCES LLC·Filed 2018·Granted May 5, 2020·3 cites·20 claims
- 0578US10870681B2CXCR4 antagonists and methods of useMainline Biosciences·Filed 2019·Granted Dec 22, 2020·2 cites·20 claims
- 0678US10351601B2CXCR4 antagonists and methods of useMainline Biosciences·Filed 2017·Granted Jul 16, 2019·4 cites·18 claims
- 0775USRE42274ECyclic peptide CXCR4 antagonistsLILLY CO ELI·Filed 2010·Granted Apr 5, 2011·3 cites·14 claims
- 0868US11753445B2Therapeutic peptidesCOHBAR INC·Filed 2022·Granted Sep 12, 2023·0 cites·31 claims
- 0964US2024082346A1Composition Comprising an Antiviral Agent and a CXCR4 Selective Antagonist and Methods For Using the SameMAINLINE BIOSCIENCES SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 1060US2025161921A1Nickel-nickel aluminum spinel-calcium hexaaluminate composite catalyst and preparation method and use thereofLANZHOU INST OF CHEMICAL PHYSICS CAS·Filed 2024·Application pending·0 cites
- 1159US7691813B2Cyclic peptide CXCR4 antagonistsLILLY CO ELI·Filed 2008·Granted Apr 6, 2010·0 cites·14 claims
- 1258US11883501B2Selective CXCR4 binding peptide conjugate and methods for making and using the sameMAINLINE BIOSCIENCES SHANGHAI CO LTD·Filed 2021·Granted Jan 30, 2024·0 cites·11 claims
- 1356US11771736B2Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the sameMAINLINE BIOSCIENCES SHANGHAI CO LTD·Filed 2018·Granted Oct 3, 2023·0 cites·16 claims
- 1447US2004039161A1Use of trichloroacetimidate linker for peptide synthesisFiled 2002·Application pending·0 cites
- 1546US2007105759A1Melanocortin receptor 4 (mc4) agonists and their usesLILLY CO ELI·Filed 2004·Application pending·0 cites
- 1645US2010130409A1Cyclic peptide cxcr4 antagonistsLILLY CO ELI·Filed 2010·Application pending·0 cites
- 1745US2006293223A1Uses of melanocortin-3 receptor (mc3r) agonist peptidesELI LILLY AND COMPANY PATENT D·Filed 2004·Application pending·0 cites
- 1820US10329162B2Methods for preparing nickel-cobalt-aluminum precursor material and cathode material with gradient distribution of aluminum elementGUANGZHOU LIBODE NEW MAT CO LTD·Filed 2016·Granted Jun 25, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Liang Zeng Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →